BTMD
BTMD
NASDAQ · Pharmaceuticals

Biote Corp -A

$1.16
+0.03 (+2.65%)
As of Nov 7, 2:26 AM ET ·
Financial Highlights (FY 2026)
Revenue
172.11M
Net Income
24.22M
Gross Margin
71.5%
Profit Margin
14.1%
Rev Growth
+5.2%
D/E Ratio
9.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 71.5% 71.5% 32.3% 32.3%
Operating Margin 18.5% 16.6% 17.4% 19.3%
Profit Margin 14.1% 13.4% 14.6% 19.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 172.11M 163.57M 22.38M 21.94M
Gross Profit 122.99M 116.89M 7.24M 7.09M
Operating Income 31.84M 27.23M 3.89M 4.25M
Net Income 24.22M 20.71M 3.27M 4.37M
Gross Margin 71.5% 71.5% 32.3% 32.3%
Operating Margin 18.5% 16.6% 17.4% 19.3%
Profit Margin 14.1% 13.4% 14.6% 19.9%
Rev Growth +5.2% +5.2% -5.1% +24.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 17.14M 17.14M 11.22M 12.91M
Total Equity 1.90M 1.90M 63.17M 61.05M
D/E Ratio 9.02 9.02 0.18 0.21
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 33.62M 30.36M 5.70M 5.36M
Free Cash Flow — — 2.62M 2.18M